Clinical Trials Browser

Phase 2 × masitinib × Myeloid × Clear all

NCT00831974 2018-12-11

Efficacy of AB1010 in Patients With Systemic Indolent Mastocytosis

Phase 2 Completed

Mastocytosis

NCT01266369 2018-12-10

Masitinib in Patients With Mastocytosis With Handicap and Bearing the D816V Mutation

Phase 2 Completed

Mastocytosis